<DOC>
	<DOC>NCT00586521</DOC>
	<brief_summary>The purpose of the study is to evaluate the effect of prophylactic treatment on the number of joint bleeds and quality of life in severe hemophilia A subjects compared to on-demand treatment in a one-group two-treatment schedule design. In addition, the effect of prophylactic treatment on the joint function, the number of all bleeds, and on the quality of life compared to on-demand treatment and health-economic data will be assessed.</brief_summary>
	<brief_title>BAY14-2222 Prophylaxis and Joint Function Improvement (Adults)</brief_title>
	<detailed_description />
	<mesh_term>Hemophilia A</mesh_term>
	<mesh_term>Hematologic Diseases</mesh_term>
	<mesh_term>Factor VIII</mesh_term>
	<criteria>Severe hemophilia A (&lt; 1% FVIII) 3045 years of age Previously treated subject (&gt; 100 Exposure days to any FVIII) Ondemand therapy with any FVIII No history of inhibitor No planned elective orthopedic surgery during the study duration (13 months) No severe concomitant disease No history of anaphylactic or other severe reaction to previous FVIII treatment</criteria>
	<gender>Male</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Coagulation Disorders</keyword>
</DOC>